STAA as reported
STAAR Surgical Company reported $290M of revenue over the trailing twelve months, +4.0% on the year before. 11 reported series are charted on this page, each one as filed.
$290M
Revenue, trailing twelve months · to Q1 2026 · +4.0% against the twelve months before
- Net Income
- −$21M
Net Income · −70% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- −$55M
Free Cash Flow · +75% year on year · trailing twelve months to Q1 2026
- Op Margin
- −20%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $290M | +4.0% | Q1 2026 |
| Net Income | −$21M | −70% | Q1 2026 |
| EPS | −$0.42 | −71% | Q1 2026 |
| Gross Margin | 76% | n/a | Q1 2026 |
| Op Margin | −20% | n/a | Q1 2026 |
| Net Margin | −14% | n/a | Q1 2026 |
| ROE | −21% | n/a | Q1 2026 |
| ROA | −16% | n/a | Q1 2026 |
| ROIC | 28% | n/a | Q3 2021 · 18 quarters behind |
| Free Cash Flow | −$55M | +75% | Q1 2026 |
| P/E | 105 | n/a | Q3 2024 · 6 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
STAAR Surgical Company (STAA) - Revenue & ProfitRevenue & ProfitSTAAR Surgical Company (STAA)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #1 of 27 by Smart Score